— Radiation sensitizer
— Intensity Modulated Radiation Therapy (IMRT)
A prospective, multi-centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma.
Veterinary and comparative oncology. [DOI] 10.1111/vco.12776. [PMID] 34655275.
C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 85(4):279-284 [PMID] 34602732.
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines
Journal of Veterinary Diagnostic Investigation. 33(2):1040638720985242-278 [DOI] 10.1177/1040638720985242. [PMID] 33446089.
Molecular diagnosis using RNAscope in-situ hybridization in canine malignancies.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 84(4):319-323 [PMID] 33012982.
Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 61(4):471-480 [DOI] 10.1111/vru.12860. [PMID] 32323424.
Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 61(3):370-378 [DOI] 10.1111/vru.12854. [PMID] 32189433.
Clinical outcome in dogs with nasal tumors treated with intensity-modulated radiation therapy.
The Canadian veterinary journal = La revue veterinaire canadienne. 51(3):293-300 [PMID] 20514254.
[Evaluation of nursing of home patients with special reference to medication].
[Hokenfu zasshi] The Japanese journal for public health nurse. 29(10):784-9 [PMID] 4491180.
Jul 2020 ACTIVE
Characterization of Expression and Prognostic Implications of GD2S and GD3S in Canine Histiocytic Sarcoma
Funding: VETERINARY CANCER SOCIETY
Jun 2019 – Sep 2021
Evaluation of novel colchicine binding site inhibitors, VERU-111, on canine malignancies in vitro
Role: Principal Investigator
Apr 2019 – Dec 2020
Development of RNA in-situ hybridization (RNAscope) to identify T regulatory cells and their function within the tumor microenvironment of canine oral malignant melanoma.
Funding: AMER KENNEL CLUB CANINE HLTH FOU
Jun 2016 – Sep 2016
D16CA-617: In Vitro Effects of the Chemotherapeutic Agent Water-Soluble Paclitaxel on Canine Mast Cell Tumor Cell Lines
Role: Principal Investigator
Funding: MORRIS ANIMAL FOU
Residency2008 · North Carolina State University
Bachelor in Veterinary Science1997 · Azabu University
VEM5872C Veterinary Medical & Radiation Oncology Clerkship
VEM5308 Vet Med Oncology
VEM5873 Oncology Clrkshp Elec
VEM5181 Radiol Tech W/Lab